Livio Trentin

Padova, IT

Expertise in

conditions

Padova, IT

Overview

Livio Trentin practices practicing medicine in Padova, Italy.

Mr. Trentin is highly rated in 24 conditions, according to our data. His clinical expertise encompasses Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Leukemia, Splenectomy, and Bone Marrow Transplant.

He is actively involved in clinical research, co-authoring 262 peer reviewed articles and participating in 3 clinical trials.

Gender

Male

Locations

Padova, Italy

Other Locations

Bolzano, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase 2 Multicenter Study to Assess the Activity and the Safety of Front-line Ibrutinib Plus Rituximab (IR) in Unfit Patients With Chronic Lymphocytic Leukemia (CLL).

Enrollment Status: Completed

Publish Date: January 16, 2025

Intervention Type: Drug

Study Drugs: Ibrutinib, Rituximab

Study Phase: Phase 2

A Retrospective Study to Evaluate the Clinical-Biologic Characteristics and Outcome of Patients Treated in Italy According to the Ibrutinib-Named Patient Program for Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Enrollment Status: Completed

Publish Date: September 13, 2021

Intervention Type: Drug

Observational Study to Assess the Efficacy and Safety of Bendamustine Plus Rituximab in Patients Affected by Chronic Lymphocytic Leukemia

Enrollment Status: Completed

Publish Date: October 06, 2020

Intervention Type: Drug

View 2 Less Clinical Trials

262 Total Publications

Correction to: DLBCL-microenvironment interactions: cytokine profiling and ECM mediated ibrutinib resistance in a 3D bone-based model.

Journal: Medical oncology (Northwood, London, England)

Published: August 26, 2026

View All 262 Publications

Frequently Asked Questions about Livio Trentin

Is Livio Trentin a top-rated expert for Chronic Lymphocytic Leukemia (CLL)?

MediFind is an objective health platform that identifies experts based on real-world data. Livio Trentin is classified as an Elite expert for Chronic Lymphocytic Leukemia (CLL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Livio Trentin participate in research or clinical trials?

Yes. Livio Trentin has published 262 articles and abstracts on conditions like Chronic Lymphocytic Leukemia (CLL). You can view a list of Livio Trentin's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Trentin's expertise for a condition

ConditionClose